Fresenius raises fiscal 2026 earnings forecasts
Statements (6)
- Bullish
Fresenius has raised its 2026 profit guidance due to strong performance in the counterfeit medicine business.
- Bullish
Fresenius is on track to meet its profit target.
- Bullish
Fresenius raised its fiscal 2026 forecast for EBIT margin.
- Bullish
Fresenius raised its fiscal 2026 forecast for core earnings per share.
- Neutral
Fresenius confirms its financial forecast.
- Neutral
Fresenius SE KGaA is being evaluated as a potential bargain on its earnings.